 The opening price for AnaptysBio, Inc. (NASDAQ:ANAB) was $75.53 and the volume amounted to 0.3 million shares which compares with the average volume of 0.44 million shares. The company stock experienced a 5.28% move to arrive at $79.23. AnaptysBio, Inc. has a consensus buy rating from 8 Wall Street analysts, and the number of shares currently sold short amount to at least 3.66% of shares outstanding. The stock spiked 22.8% last month and is up 366.06 this year. Wall Street is only getting more bullish on the stock, with 8 of analysts who cover ANAB having a buy-equivalent rating. Analysts have placed a $87.63 price target on AnaptysBio, Inc., suggesting a 10.6% gain from recent close. It’s currently trading about 0.06% above its 52-week high. AnaptysBio, Inc. (ANAB) surprised the stock market in its last reported earnings when it earned $0.99 a piece versus the consensus-estimated $0.86. Its revenue totaled $2.32 million down -66.86% from the previous quarter.  This stock (ANAB) is ahead of its 52-week low with 422.28%. Its last month’s stock price volatility remained 5.8% which for the week stands at 4.99%. The share price has moved forward from its 20 days moving average, trading at a distance of 16.37% and stays 45.62% away from its 50 days moving average. Over the last five days, shares have managed 11.47% gains and now is up 145.21% since hitting its 200-day moving average of $35.54. AnaptysBio, Inc. (ANAB) has made its way to a 12-month decline of 0%. Turning to China Life Insurance Company Limited (NYSE:LFC), its shares were trading at $17.71 a gain of $0.59, on the trading floor. The stock, after opening at $17.73, touched a high of $17.77 before paring much of its gains. So far, analysts are sticking with their bullish recommendations with the consensus call at 1. China Life Insurance Company Limited has 2 buy ratings, 0 holds and 0 sells even after the stock tumbled -0.78% from its high of $17.85 to a $134.73 billion market value through last close. The company’s consensus rating on Reuter’s scale remained unchanged from 1 to 1 during a month. Analysts set a 12-month price target of $19.39 a share. The target implies a 9.49% spike from where the shares are currently trading. Also, the current price highlights a discount of 1.36% to analysts’ high consensus price target. The counter witnessed a trading volume of 0.51 million shares versus an average volume of 0.52 million shares during last trading session. Its last month’s stock price volatility remained 0.83% which for the week approaches 1.23%. The lowest price the stock reached in the last trading day was $17.68 and compares with the $12.74 52-week low. The stock recovered 39.01% since its low point and has performed 37.61% year-to-date.